In a filing, CME Group Inc revealed its Director Carey Charles P unloaded Company’s shares for reported $0.13 million on Jun 10 ’25. In the deal valued at $265.35 per share,500 shares were sold. As a result of this transaction, Carey Charles P now holds 4,900 shares worth roughly $1.31 million.
Then, Carey Charles P bought 500 shares, generating $143,185 in total proceeds.
Before that, Kaye Daniel G sold 500 shares. CME Group Inc shares valued at $141,210 were divested by the Director at a price of $282.42 per share. As a result of the transaction, Kaye Daniel G now holds 3,668 shares, worth roughly $0.98 million.
Morgan Stanley upgraded its CME Group Inc [CME] rating to an Overweight from a an Equal-weight in a research note published recently. A number of analysts have revised their coverage, including Raymond James’s analysts, who increased its forecast for the stock in early March from “a Mkt perform” to “an Outperform”. Citigroup also remained covering CME and has decreased its forecast on January 06, 2025 with a “Neutral” recommendation from previously “Buy” rating. Redburn Atlantic revised its rating on October 08, 2024. It rated CME as “a Neutral” which previously was an “a Buy”.
Price Performance Review of CME
On Monday, CME Group Inc [NASDAQ:CME] saw its stock fall -0.74% to $267.51. Over the last five days, the stock has lost -0.31%. CME Group Inc shares have risen nearly 15.19% since the year began. Nevertheless, the stocks have risen 40.07% over the past one year. While a 52-week high of $290.79 was reached on 06/02/25, a 52-week low of $186.08 was recorded on 01/07/25.
Levels Of Support And Resistance For CME Stock
The 24-hour chart illustrates a support level at 265.36, which if violated will result in even more drops to 263.21. On the upside, there is a resistance level at 270.30. A further resistance level may holdings at 273.09.
The most recent change occurred on September 27, 2024 when RBC Capital Mkts began covering the stock and recommended ‘”a Sector perform”‘ rating along with a $235 price target.